APA (7th ed.) Citation

Peyrin‐Biroulet, L., Arkkila, P., Armuzzi, A., Danese, S., Ferrante, M., Jordi Guardiola, . . . Atreya, R. (2024, March). Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials. BMC Gastroenterology.

Chicago Style (17th ed.) Citation

Peyrin‐Biroulet, Laurent, et al. "Comparative Efficacy and Safety of Subcutaneous Infliximab and Vedolizumab in Patients with Crohn’s Disease and Ulcerative Colitis Included in Randomised Controlled Trials." BMC Gastroenterology Mar. 2024.

MLA (9th ed.) Citation

Peyrin‐Biroulet, Laurent, et al. "Comparative Efficacy and Safety of Subcutaneous Infliximab and Vedolizumab in Patients with Crohn’s Disease and Ulcerative Colitis Included in Randomised Controlled Trials." BMC Gastroenterology, Mar. 2024.